Memory Pharmaceuticals Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
55
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$50M
Memory Pharmaceuticals General Information
Description
Developer of drugs for the treatment of central nervous system conditions. The company is focused on the discovery and development of innovative drug candidates for the treatment of a range of central nervous system conditions, many of which exhibit impairment of memory and other cognitive functions.
Contact Information
Corporate Office
- 100 Philips Parkway
- Montvale, NJ 07645
- United States
Corporate Office
- 100 Philips Parkway
- Montvale, NJ 07645
- United States
Memory Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 31-Dec-2008 | $50M | Completed | Generating Revenue | ||
| 9. PIPE | 20-Jun-2007 | Completed | Generating Revenue | |||
| 8. Debt - General | 29-Mar-2007 | Completed | Generating Revenue | |||
| 7. PIPE | 20-Dec-2005 | Completed | Generating Revenue | |||
| 6. PIPE | 05-Oct-2005 | Completed | Generating Revenue | |||
| 5. IPO | 05-Apr-2004 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 25-Mar-2002 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 01-May-2000 | Completed | Product Development | |||
| 2. Early Stage VC (Series B) | 01-Feb-1999 | $10.8M | $11.8M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Apr-1998 | $1M | $1M | Completed | Startup |
Memory Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 6,150,000 | $0.001000 | 8% | $1.75 | $1.75 | $1.75 | 16.43% | |
| Series A | 1,000,000 | $0.001000 | 8% | $1 | $1 | $1 | 2.67% |
Memory Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Memory Pharmaceuticals Patents
Memory Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20100056491-A1 | 4'-amino cyclic compounds having 5-ht6 receptor affinity | Inactive | 29-Aug-2008 | ||
| WO-2010024980-A1 | 4'-amino cyclic compounds having 5-ht6 receptor affinity | Inactive | 29-Aug-2008 | ||
| US-20100056531-A1 | Alkyl-substituted 3' compounds having 5-ht6 receptor affinity | Inactive | 22-Aug-2008 | ||
| WO-2010021797-A1 | Condensed heterocyclic compounds having 5-ht6 receptor affinity | Inactive | 22-Aug-2008 | ||
| US-20100029629-A1 | Acyclic compounds having 5-ht6 receptor affinity | Inactive | 25-Jul-2008 | C07D471/04 |
Memory Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Memory Pharmaceuticals Former Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alta Partners | Venture Capital | Minority | ||
| Astellas Venture Management | Corporate Venture Capital | Minority | ||
| BioVeda Capital | Venture Capital | Minority | ||
| EuclidSR Partners | Venture Capital | Minority | ||
| Gimv | PE/Buyout | Minority |
Memory Pharmaceuticals FAQs
-
When was Memory Pharmaceuticals founded?
Memory Pharmaceuticals was founded in 1997.
-
Where is Memory Pharmaceuticals headquartered?
Memory Pharmaceuticals is headquartered in Montvale, NJ.
-
What is the size of Memory Pharmaceuticals?
Memory Pharmaceuticals has 55 total employees.
-
What industry is Memory Pharmaceuticals in?
Memory Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Memory Pharmaceuticals a private or public company?
Memory Pharmaceuticals is a Private company.
-
What is the current valuation of Memory Pharmaceuticals?
The current valuation of Memory Pharmaceuticals is .
-
What is Memory Pharmaceuticals’s current revenue?
The current revenue for Memory Pharmaceuticals is .
-
How much funding has Memory Pharmaceuticals raised over time?
Memory Pharmaceuticals has raised $171M.
-
Who are Memory Pharmaceuticals’s investors?
Alta Partners, Astellas Venture Management, BioVeda Capital, EuclidSR Partners, and Gimv are 5 of 22 investors who have invested in Memory Pharmaceuticals.
-
When was Memory Pharmaceuticals acquired?
Memory Pharmaceuticals was acquired on 31-Dec-2008.
-
Who acquired Memory Pharmaceuticals?
Memory Pharmaceuticals was acquired by Roche.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
